BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16293787)

  • 1. Phospholipase C epsilon modulates beta-adrenergic receptor-dependent cardiac contraction and inhibits cardiac hypertrophy.
    Wang H; Oestreich EA; Maekawa N; Bullard TA; Vikstrom KL; Dirksen RT; Kelley GG; Blaxall BC; Smrcka AV
    Circ Res; 2005 Dec; 97(12):1305-13. PubMed ID: 16293787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure.
    Oudit GY; Crackower MA; Eriksson U; Sarao R; Kozieradzki I; Sasaki T; Irie-Sasaki J; Gidrewicz D; Rybin VO; Wada T; Steinberg SF; Backx PH; Penninger JM
    Circulation; 2003 Oct; 108(17):2147-52. PubMed ID: 12963636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epac and phospholipase Cepsilon regulate Ca2+ release in the heart by activation of protein kinase Cepsilon and calcium-calmodulin kinase II.
    Oestreich EA; Malik S; Goonasekera SA; Blaxall BC; Kelley GG; Dirksen RT; Smrcka AV
    J Biol Chem; 2009 Jan; 284(3):1514-22. PubMed ID: 18957419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.
    Most P; Seifert H; Gao E; Funakoshi H; Völkers M; Heierhorst J; Remppis A; Pleger ST; DeGeorge BR; Eckhart AD; Feldman AM; Koch WJ
    Circulation; 2006 Sep; 114(12):1258-68. PubMed ID: 16952982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development.
    Bai Y; Edamatsu H; Maeda S; Saito H; Suzuki N; Satoh T; Kataoka T
    Cancer Res; 2004 Dec; 64(24):8808-10. PubMed ID: 15604236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of the inducible 70-kDa heat shock protein genes in mice impairs cardiac contractile function and calcium handling associated with hypertrophy.
    Kim YK; Suarez J; Hu Y; McDonough PM; Boer C; Dix DJ; Dillmann WH
    Circulation; 2006 Jun; 113(22):2589-97. PubMed ID: 16735677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
    Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
    Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy.
    Jaffré F; Bonnin P; Callebert J; Debbabi H; Setola V; Doly S; Monassier L; Mettauer B; Blaxall BC; Launay JM; Maroteaux L
    Circ Res; 2009 Jan; 104(1):113-23. PubMed ID: 19023134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of ultraviolet B-induced skin tumor development in phospholipase Cε-knockout mice is associated with decreased cell death.
    Oka M; Edamatsu H; Kunisada M; Hu L; Takenaka N; Dien S; Sakaguchi M; Kitazawa R; Norose K; Kataoka T; Nishigori C
    Carcinogenesis; 2010 Oct; 31(10):1897-902. PubMed ID: 20688835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuregulins regulate cardiac parasympathetic activity: muscarinic modulation of beta-adrenergic activity in myocytes from mice with neuregulin-1 gene deletion.
    Okoshi K; Nakayama M; Yan X; Okoshi MP; Schuldt AJ; Marchionni MA; Lorell BH
    Circulation; 2004 Aug; 110(6):713-7. PubMed ID: 15289373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcoplasmic reticulum calcium overloading in junctin deficiency enhances cardiac contractility but increases ventricular automaticity.
    Yuan Q; Fan GC; Dong M; Altschafl B; Diwan A; Ren X; Hahn HH; Zhao W; Waggoner JR; Jones LR; Jones WK; Bers DM; Dorn GW; Wang HS; Valdivia HH; Chu G; Kranias EG
    Circulation; 2007 Jan; 115(3):300-9. PubMed ID: 17224479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin inhibits beta-adrenergic action in ischemic/reperfused heart: a novel mechanism of insulin in cardioprotection.
    Yu QJ; Si R; Zhou N; Zhang HF; Guo WY; Wang HC; Gao F
    Apoptosis; 2008 Feb; 13(2):305-17. PubMed ID: 18165901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of AT1 receptor in isoproterenol-induced cardiac hypertrophy and oxidative stress in mice.
    Zhang GX; Ohmori K; Nagai Y; Fujisawa Y; Nishiyama A; Abe Y; Kimura S
    J Mol Cell Cardiol; 2007 Apr; 42(4):804-11. PubMed ID: 17350036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy.
    El-Armouche A; Wittköpper K; Degenhardt F; Weinberger F; Didié M; Melnychenko I; Grimm M; Peeck M; Zimmermann WH; Unsöld B; Hasenfuss G; Dobrev D; Eschenhagen T
    Cardiovasc Res; 2008 Dec; 80(3):396-406. PubMed ID: 18689792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epac-mediated activation of phospholipase C(epsilon) plays a critical role in beta-adrenergic receptor-dependent enhancement of Ca2+ mobilization in cardiac myocytes.
    Oestreich EA; Wang H; Malik S; Kaproth-Joslin KA; Blaxall BC; Kelley GG; Dirksen RT; Smrcka AV
    J Biol Chem; 2007 Feb; 282(8):5488-95. PubMed ID: 17178726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenergic pathways and left ventricular remodeling.
    Dorn GW
    J Card Fail; 2002 Dec; 8(6 Suppl):S370-3. PubMed ID: 12555147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional FKBP12.6 overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling.
    Gellen B; Fernández-Velasco M; Briec F; Vinet L; LeQuang K; Rouet-Benzineb P; Bénitah JP; Pezet M; Palais G; Pellegrin N; Zhang A; Perrier R; Escoubet B; Marniquet X; Richard S; Jaisser F; Gómez AM; Charpentier F; Mercadier JJ
    Circulation; 2008 Apr; 117(14):1778-86. PubMed ID: 18378612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CaMKII-mediated increased lusitropic responses to beta-adrenoreceptor stimulation in ANP-receptor deficient mice.
    Yurukova S; Kilić A; Völker K; Leineweber K; Dybkova N; Maier LS; Brodde OE; Kuhn M
    Cardiovasc Res; 2007 Mar; 73(4):678-88. PubMed ID: 17107670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression.
    Perrino C; Naga Prasad SV; Patel M; Wolf MJ; Rockman HA
    J Am Coll Cardiol; 2005 Jun; 45(11):1862-70. PubMed ID: 15936620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Novel concepts in beta-adrenergic receptor signaling: therapeutic options for heart failure].
    Schiattarella GG; Perrino C; Gargiulo G; Sorrentino S; Franzone A; Capretti G; Esposito G; Chiariello M
    G Ital Cardiol (Rome); 2010 Mar; 11(3):221-8. PubMed ID: 20550062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.